ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.946,17
-0,29%
S&P 500
5.868,55
-0,22%
Dow Jones
42.392,27
-0,36%
Euro vs US Dollar
1,02883
0,20%
Bitcoin
96.360,00
-0,55%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. PROCEPT BioRobotics Corporation (PRCT)

  7. PROCEPT BioRobotics Corporation (PRCT) News

PRCT

PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PRCT
DatumZeitQuelleÜberschriftSymbolFirma
06/12/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
06/12/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
04/12/202422h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
04/12/202422h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
02/12/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
27/11/202422h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
26/11/202422h05GlobeNewswire Inc.PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024NASDAQ:PRCTPROCEPT BioRobotics Corporation
22/11/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
20/11/202422h29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
15/11/202422h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
13/11/202422h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
08/11/202402h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
05/11/202422h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
31/10/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
31/10/202421h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRCTPROCEPT BioRobotics Corporation
30/10/202421h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRCTPROCEPT BioRobotics Corporation
30/10/202401h43GlobeNewswire Inc.PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common StockNASDAQ:PRCTPROCEPT BioRobotics Corporation
28/10/202421h19GlobeNewswire Inc.PROCEPT BioRobotics Corporation Announces Proposed Offering of Common StockNASDAQ:PRCTPROCEPT BioRobotics Corporation
28/10/202421h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRCTPROCEPT BioRobotics Corporation
28/10/202421h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRCTPROCEPT BioRobotics Corporation
28/10/202412h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRCTPROCEPT BioRobotics Corporation
28/10/202412h00PR Newswire (US)Deborah Kilpatrick Joins Sonder Capital as its Newest Venture PartnerNASDAQ:PRCTPROCEPT BioRobotics Corporation
28/10/202412h00GlobeNewswire Inc.PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA GuidanceNASDAQ:PRCTPROCEPT BioRobotics Corporation
28/10/202411h12IH Market NewsUS Futures Rise; Oil Prices Drop Over 5% as Middle East Tensions EaseNASDAQ:PRCTPROCEPT BioRobotics Corporation
17/10/202422h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
09/10/202422h04GlobeNewswire Inc.PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024NASDAQ:PRCTPROCEPT BioRobotics Corporation
07/10/202422h04GlobeNewswire Inc.PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate CancerNASDAQ:PRCTPROCEPT BioRobotics Corporation
18/09/202423h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
16/09/202423h47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
13/09/202402h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
 Showing the most relevant articles for your search:NASDAQ:PRCT

Kürzlich von Ihnen besucht

BIT
XDWT
Xtrackers Msci World Inf...
BIT
F34766
Vontobel Financial Produ...
BIT
IB25
Exchange Traded
BIT
UB8C6N
Unicredit Bank
BIT
F21330
Vontobel Financial Produ...
BIT
F38716
Vontobel Financial Produ...
AQSE
DUKE.GB
Duke Capital
BIT
ESEH
BNP Paribas Theam S&P 50...
BIT
I07575
INTESA SANPAOLO
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten